Home
Random
Log in
Settings
About HemOnc.org - A Hematology Oncology Wiki
Disclaimers
HemOnc.org - A Hematology Oncology Wiki
Search
Category
:
FDA approved in 2022
Language
Watch
View source
Pages in category "FDA approved in 2022"
The following 22 pages are in this category, out of 22 total.
A
Adagrasib (Krazati)
B
Bevacizumab-adcd (Vegzelga)
Bevacizumab-maly (Alymsys)
C
Ciltacabtagene autoleucel (Carvykti)
E
Etranacogene dezaparvovec (Hemgenix)
F
Filgrastim-ayow (Releuko)
Futibatinib (Lytgobi)
G
Gallium Ga 68 gozetotide (Locametz)
L
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)
M
Mirvetuximab soravtansine (Elahere)
Mitapivat (Pyrukynd)
Mosunetuzumab (Lunsumio)
N
Nadofaragene firadenovec (Adstiladrin)
Nivolumab and relatlimab (Opdualag)
O
Olutasidenib (Rezlidhia)
P
Pacritinib (Vonjo)
Pegfilgrastim-fpgk (Stimufend)
Pegfilgrastim-pbbk (Fylnetra)
S
Sutimlimab (Enjaymo)
T
Tebentafusp (Kimmtrak)
Teclistamab (Tecvayli)
Tremelimumab (Imjudo)